References
Original articles
Merola, J. F. et al. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind placebo-controlled, phase 3 trial (BE COMPLETE). Lancet https://doi.org/10.1016/S0140-6736(22)02303-0 (2022)
McInnes, I. B. et al. Bimekizumab in patients with active psoriatic arthritis, naïve to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet https://doi.org/10.1016/S0140-6736(22)02302-9 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McHugh, J. Bimekizumab safe and effective for psoriatic arthritis. Nat Rev Rheumatol 19, 64 (2023). https://doi.org/10.1038/s41584-022-00903-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-022-00903-3
- Springer Nature Limited